Related Experiment Video
Updated: Jul 12, 2026
14:58
A Simplified Technique for In situ Excision of Cornea and Evisceration of Retinal Tissue from Human Ocular Globe
Published on: June 12, 2012
Human excimer laser keratectomy. Short-term histopathology
Bulletin of the New York Academy of Medicine
|June 1, 1989
Summary
The first human trial used an argon fluoride excimer laser for superficial keratectomy. Further research is needed to confirm long-term safety and efficacy for refractive surgery.
Area of Science:
- Ophthalmology
- Surgical Technology
- Biomedical Engineering
Background:
- The study introduces the first human trial of argon fluoride excimer laser for superficial keratectomy.
- This technique shows promise for future reconstructive and refractive keratoplasty.
Observation:
- The initial trial involved three human eyes, with clinical and short-term histopathologic evaluation.
- The argon fluoride excimer laser was used at a 193 nm wavelength.
Findings:
- The laser superficial keratectomy procedure was successfully performed in the initial human subjects.
- Short-term (less than 14 days) evaluation of clinical appearance and histopathology was conducted.
Implications:
- Extensive investigation into corneal wound healing post-laser ablation is crucial.
- Long-term stability of corneal excisions and refractive corrections requires thorough analysis.
- Optimal laser parameters and comprehensive analysis of laser-tissue interactions are essential for advancing corneal surgery.
